Harvey M. Golomb to Adult
This is a "connection" page, showing publications Harvey M. Golomb has written about Adult.
Connection Strength
0.409
-
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. J Immunother Cancer. 2018 07 16; 6(1):73.
Score: 0.011
-
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
Score: 0.009
-
Familial myeloid leukemia associated with loss of the long arm of chromosome 5. Leukemia. 1996 Apr; 10(4):669-74.
Score: 0.009
-
Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol. 1995 Apr; 13(4):974-82.
Score: 0.008
-
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
Score: 0.008
-
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515. Leukemia. 1994 Dec; 8(12):2037-40.
Score: 0.008
-
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Semin Oncol. 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4.
Score: 0.008
-
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma. 1994; 14 Suppl 1:89-93.
Score: 0.008
-
Hairy cell leukaemia. Baillieres Clin Haematol. 1993 Dec; 6(4):887-98.
Score: 0.008
-
Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986. Leukemia. 1992 Nov; 6(11):1177-80.
Score: 0.007
-
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
Score: 0.007
-
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
Score: 0.006
-
Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
Score: 0.006
-
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP. Leukemia. 1990 Feb; 4(2):127-31.
Score: 0.006
-
Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
Score: 0.006
-
Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
Score: 0.006
-
Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro? Cancer. 1989 Jul 15; 64(2):374-8.
Score: 0.006
-
Cytogenetic abnormalities in a secondary lymphoma complicating cardiac transplantation. Leukemia. 1989 Apr; 3(4):303-4.
Score: 0.006
-
High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989 Jan 15; 63(2):238-42.
Score: 0.005
-
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
Score: 0.005
-
Skeletal complications in hairy cell leukemia: diagnosis and therapy. J Clin Oncol. 1988 Aug; 6(8):1280-4.
Score: 0.005
-
Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
Score: 0.005
-
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin Oncol. 1987 Jun; 14(2 Suppl 2):13-7.
Score: 0.005
-
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):311-2.
Score: 0.005
-
Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. 1986 Oct; 100(4):621-8.
Score: 0.005
-
The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
Score: 0.005
-
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
Score: 0.005
-
Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
Score: 0.005
-
Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease. Cancer. 1986 Feb 01; 57(3):471-6.
Score: 0.004
-
Second malignancies in hairy cell leukemia. Cancer. 1985 Sep 15; 56(6):1462-7.
Score: 0.004
-
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
Score: 0.004
-
Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80.
Score: 0.004
-
Current concepts in small cell carcinoma of the lung. CA Cancer J Clin. 1984 Sep-Oct; 34(5):269-81.
Score: 0.004
-
Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. N Engl J Med. 1984 Jan 26; 310(4):263-4.
Score: 0.004
-
Hairy cell leukemia: the importance of accurate diagnosis and sequential management. Adv Intern Med. 1984; 29:245-69.
Score: 0.004
-
Hairy cell leukemia: lessons learned in twenty-five years. J Clin Oncol. 1983 Oct; 1(10):652-6.
Score: 0.004
-
Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1983 Sep; 67(9):831-2.
Score: 0.004
-
Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
Score: 0.004
-
Guided biopsies of abnormalities on nuclear bone scans. Technique and indications. J Thorac Cardiovasc Surg. 1983 Mar; 85(3):396-403.
Score: 0.004
-
Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52.
Score: 0.004
-
Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia. Am J Hematol. 1983 Feb; 14(1):49-56.
Score: 0.004
-
Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11.
Score: 0.004
-
Phagocytic capacity of hairy cells from seventeen patients. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 40(3):327-37.
Score: 0.003
-
Phospholipid and cholesterol differences amongst leukemic cell types with special reference to hairy cell leukemia: a preliminary report. Clin Chim Acta. 1981 Nov 11; 116(3):311-8.
Score: 0.003
-
Significance of cytogenetic abnormalities in acute leukemias. Hum Pathol. 1981 Jun; 12(6):515-22.
Score: 0.003
-
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000 Nov 01; 96(9):2981-6.
Score: 0.003
-
Non-Hodgkin lymphoma. Introduction. Semin Oncol. 1980 Sep; 7(3):221-2.
Score: 0.003
-
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5.
Score: 0.003
-
Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q. Genes Chromosomes Cancer. 2000 Jun; 28(2):164-72.
Score: 0.003
-
The benefits of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy. A guide to appropriate therapy. Chest. 1980 May; 77(5):647-50.
Score: 0.003
-
"Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. Blood. 1980 Feb; 55(2):253-9.
Score: 0.003
-
The non-Hodgkin lymphomas. Curr Probl Cancer. 1980 Jan; 4(7):1-35.
Score: 0.003
-
Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27.
Score: 0.003
-
Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979 Aug; 39(8):3119-28.
Score: 0.003
-
Splenectomy as initial therapy in twenty-six patients with leukemic reticuloendotheliosis (hairy cell leukemia). Cancer Res. 1979 Jul; 39(7 Pt 1):2366-70.
Score: 0.003
-
Hairy cell leukemia: differences in phagocytic capacity of cells in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979 May 04; 30(1):1-13.
Score: 0.003
-
Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49.
Score: 0.003
-
Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
Score: 0.003
-
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
Score: 0.003
-
Disseminated atypical mycobacterial infection in hairy-cell leukaemia. Lancet. 1978 Nov 11; 2(8098):1052-3.
Score: 0.003
-
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978 Nov; 89(5 Pt 1):677-83.
Score: 0.003
-
Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9.
Score: 0.003
-
Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77.
Score: 0.003
-
Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug; 42(2 Suppl):946-56.
Score: 0.003
-
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
Score: 0.003
-
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
Score: 0.003
-
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
Score: 0.003
-
Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978 Apr; 41(4):1374-80.
Score: 0.003
-
Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70.
Score: 0.003
-
Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64.
Score: 0.003
-
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol. 1997 Mar; 15(3):884-92.
Score: 0.002
-
Oncology and the reproductive years: an invitational symposium. J Reprod Med. 1976 Oct; 17(4):189-90.
Score: 0.002
-
An approach to general oncology: principles and procedures. J Reprod Med. 1976 Oct; 17(4):191-7.
Score: 0.002
-
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
Score: 0.002
-
Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21.
Score: 0.002
-
Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul; 136(7):825-8.
Score: 0.002
-
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
Score: 0.002
-
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago. Semin Oncol. 1996 Jun; 23(3 Suppl 7):15-8.
Score: 0.002
-
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Semin Oncol. 1996 Apr; 23(2 Suppl 5):11-8.
Score: 0.002
-
Human cord blood lymphocytes. Ultrastructural and immunologic surface marker characteristics; a comparison with B- and T-cell lymphomas. Lab Invest. 1976 Feb; 34(2):207-15.
Score: 0.002
-
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
Score: 0.002
-
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):38-41.
Score: 0.002
-
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia. 1995 Jul; 9(7):1116-20.
Score: 0.002
-
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer. Semin Oncol. 1995 Apr; 22(2 Suppl 5):30-7; discussion 41-4.
Score: 0.002
-
Cervical synovial sarcoma at the bifurcation of the carotid artery. Cancer. 1975 Feb; 35(2):483-9.
Score: 0.002
-
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
Score: 0.002
-
Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
Score: 0.002
-
A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients. Eur J Cancer. 1991; 27(2):217-8.
Score: 0.002
-
Analysis of human chromosomal variants by quantitative electron microscopy. II. Ring chromosome 18. Chromosoma. 1971; 34(1):94-8.
Score: 0.002
-
Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
Score: 0.002
-
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990 Feb; 5(2):129-33.
Score: 0.001
-
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
Score: 0.001
-
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
Score: 0.001
-
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):171-85.
Score: 0.001
-
The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):203-16.
Score: 0.001
-
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
Score: 0.001
-
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
Score: 0.001
-
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
Score: 0.001
-
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
Score: 0.001
-
Regional accuracy of computed tomography of the mediastinum in staging of lung cancer. J Thorac Cardiovasc Surg. 1986 Apr; 91(4):498-504.
Score: 0.001
-
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
Score: 0.001
-
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
Score: 0.001
-
Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
Score: 0.001
-
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report. Cancer. 1986 Jan 01; 57(1):44-53.
Score: 0.001
-
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol. 1985 Dec; 3(12):1596-604.
Score: 0.001
-
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients. Cancer. 1985 Nov 15; 56(10):2385-90.
Score: 0.001
-
Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct; 3(10):1309-17.
Score: 0.001
-
Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun; 3(6):758-68.
Score: 0.001
-
Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
Score: 0.001
-
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41.
Score: 0.001
-
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41.
Score: 0.001
-
The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
Score: 0.001
-
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6.
Score: 0.001
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
Score: 0.001
-
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
Score: 0.001
-
Increased cholesterol biosynthesis in leukemic cells from patients with hairy cell leukemia. Blood. 1983 Jan; 61(1):50-60.
Score: 0.001
-
Unique cell surface glycoprotein expression in hairy cell leukemia: effect of phorbol ester tumor promoters on surface glycoproteins, cell morphology, and adherence. Cancer Res. 1982 Sep; 42(9):3724-8.
Score: 0.001
-
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings. Cancer. 1982 Jun 01; 49(11):2222-5.
Score: 0.001
-
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
Score: 0.001
-
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
Score: 0.001
-
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
Score: 0.001
-
Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study. Cancer Treat Rep. 1982 Apr; 66(4):733-41.
Score: 0.001
-
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
Score: 0.001
-
Lymphoblastic lymphoma in adults. Cancer. 1981 May 15; 47(10):2510-6.
Score: 0.001
-
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer. 1981 Feb 15; 47(4):748-56.
Score: 0.001
-
Late relapses in Hodgkin disease. Am J Hematol. 1981; 10(1):31-6.
Score: 0.001
-
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
Score: 0.001
-
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med. 1980 Jun; 92(6):785-90.
Score: 0.001
-
Chromosomes and causation of human cancer and leukemia. XXXV. The missing Y in acute non-lymphocytic leukemia (ANLL). Cancer. 1980 Jan 01; 45(1):84-90.
Score: 0.001
-
Chromosome analysis of primary large bowel tumors: a new method for improving the yield of analyzable metaphases. Cancer. 1979 Nov; 44(5):1656-64.
Score: 0.001
-
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
Score: 0.001
-
B cell acute lymphoblastic leukemia (ALL) with a 14q+ chromosome abnormality. Blood. 1979 Feb; 53(2):235-43.
Score: 0.001
-
Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer. 1978 Oct; 42(4):1760-5.
Score: 0.001
-
Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 1978 Aug; 52(2):272-80.
Score: 0.001
-
Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
Score: 0.001
-
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
Score: 0.001
-
Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
Score: 0.001
-
Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer. 1977 Dec 15; 20(6):869-72.
Score: 0.001
-
The clinical features of chronic lymphocytic leukaemia. Clin Haematol. 1977 Feb; 6(1):185-202.
Score: 0.001
-
Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan; 39(1):342-6.
Score: 0.001
-
Idiopathic acquired refractory sideroblastic anemia: Banded chromosome analysis in six patients. Acta Haematol. 1977; 57(1):15-23.
Score: 0.001
-
Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy. Cancer. 1976 Feb; 37(2):629-36.
Score: 0.001
-
Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med. 1974 Nov; 81(5):601-8.
Score: 0.001
-
Identification of a C6-G21 translocation chromosome by the Q-M and Giemsa banding techniques in a patient with Down's syndrome, with possible assignment of Gm locus. Clin Genet. 1973; 4(1):53-7.
Score: 0.000